Home arrow Business arrow Pharmaceutical Industry arrow India's copycat drug firms bid for healthy future in basic research
Stock MarketsU.S. EconomyEuropean Business & EconomyCompany Earnings
Personal FinancePharmaceutical IndustryReal Estate Industry
India's copycat drug firms bid for healthy future in basic research
AFP   Sunday, 10 December 2006

A worker sweeps a corridor at the Nicholas Piramal Research Centre in Mumbai. India's pharmaceutical companies, which amassed fortunes copying generic drugs from the West, are facing up to the challenge of developing their own medicines. Nicholas Piramal India Ltd (NPIL), the country's fourth-biggest drug company, wants to be the first local laboratory to discover, patent and market original drugs.(AFP/File/Sebastian D'Souza)AFP - India's pharmaceutical companies, which amassed fortunes copying generic drugs from the West, are facing up to the challenge of developing their own medicines.
Read more...